BSE Live
Dec 13, 16:00Prev. Close
2.10
Open Price
1.90
Bid Price (Qty.)
2.10 (4839)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Nutraplus India (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -14.03 | 0.65 | 0.04 | -2.39 | 6.64 | |
| Diluted EPS (Rs.) | -14.03 | 0.65 | 0.04 | -2.39 | 6.33 | |
| Cash EPS (Rs.) | -12.65 | 1.82 | 1.18 | -1.19 | 7.62 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 6.34 | 20.37 | 19.72 | 19.72 | 49.64 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 6.34 | 20.37 | 19.72 | 19.72 | 49.64 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | |
| Revenue from Operations/Share (Rs.) | 31.29 | 40.94 | 32.01 | 26.71 | 61.24 | |
| PBDIT/Share (Rs.) | -10.47 | 4.85 | 2.76 | -0.47 | 9.82 | |
| PBIT/Share (Rs.) | -11.85 | 3.67 | 1.63 | -1.12 | 8.47 | |
| PBT/Share (Rs.) | -14.03 | 0.99 | 0.26 | -2.59 | 5.57 | |
| Net Profit/Share (Rs.) | -14.03 | 0.64 | 0.04 | -1.84 | 6.26 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -33.46 | 11.84 | 8.63 | -1.77 | 16.04 | |
| PBIT Margin (%) | -37.86 | 8.95 | 5.07 | -4.20 | 13.83 | |
| PBT Margin (%) | -44.83 | 2.40 | 0.80 | -9.70 | 9.10 | |
| Net Profit Margin (%) | -44.83 | 1.56 | 0.12 | -6.87 | 10.22 | |
| Return on Networth / Equity (%) | -221.26 | 3.15 | 0.20 | -9.31 | 12.61 | |
| Return on Capital Employed (%) | -178.18 | 11.72 | 5.09 | -3.85 | 7.73 | |
| Return on Assets (%) | -42.83 | 1.29 | 0.08 | -3.67 | 4.79 | |
| Total Debt/Equity (X) | 3.51 | 0.96 | 1.00 | 0.87 | 1.05 | |
| Asset Turnover Ratio (%) | 95.53 | 82.23 | 63.51 | 53.47 | 46.85 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.20 | 1.11 | 1.23 | 1.16 | 1.51 | |
| Quick Ratio (X) | 0.16 | 0.52 | 0.84 | 0.84 | 1.10 | |
| Inventory Turnover Ratio (X) | 30.01 | 3.76 | 4.38 | 4.06 | 2.99 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 8.40 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 6.91 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 91.60 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 93.09 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 93.32 | 113.57 | 165.61 | 137.68 | 306.03 | |
| EV/Net Operating Revenue (X) | 0.87 | 0.81 | 1.52 | 1.51 | 3.94 | |
| EV/EBITDA (X) | -2.61 | 6.87 | 17.58 | -85.28 | 24.58 | |
| MarketCap/Net Operating Revenue (X) | 0.17 | 0.35 | 0.92 | 0.89 | 3.13 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 91.59 | |
| Price/BV (X) | 0.85 | 0.70 | 1.50 | 1.21 | 3.86 | |
| Price/Net Operating Revenue | 0.17 | 0.35 | 0.92 | 0.89 | 3.13 | |
| Earnings Yield | -2.62 | 0.04 | 0.00 | -0.08 | 0.03 |
29.05.2019
Nutraplus India Standalone March 2019 Net Sales at Rs 35.80 crore, up 2.2% Y-o-Y
18.02.2019
Nutraplus India Standalone December 2018 Net Sales at Rs 42.94 crore, up 37.89% Y-o-Y
15.11.2018
Nutraplus India Standalone September 2018 Net Sales at Rs 32.09 crore, up 30.95% Y-o-Y
07.02.2017
Stocks in news: Idea, Bharti Infra, Titagarh, Honeywell, Caplin
29.05.2019
Nutraplus India Standalone March 2019 Net Sales at Rs 35.80 crore, up 2.2% Y-o-Y
18.02.2019
Nutraplus India Standalone December 2018 Net Sales at Rs 42.94 crore, up 37.89% Y-o-Y
15.11.2018
Nutraplus India Standalone September 2018 Net Sales at Rs 32.09 crore, up 30.95% Y-o-Y
17.08.2015
Nutraplus India consolidated Jun '15 sales at Rs 15.28 crore
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
08.04.2026
08.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth